Catherine A Schnabel

Title: The Innovative Contributions of Catherine A. Schnabel

Introduction

Catherine A. Schnabel is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer research, particularly in breast cancer and neuroendocrine tumors. With a total of five patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

One of her latest patents focuses on the integration of tumor characteristics with a breast cancer index. This patent outlines methods for determining the risk of recurrence of breast cancer in subjects. It also provides methods for predicting responsiveness to therapy for breast cancer patients. Additionally, her patent includes recommendations for treatment options for individuals diagnosed with breast cancer. Furthermore, it describes systems for performing these methods effectively. Another notable patent involves neuroendocrine tumors, where she provides methods for using gene expression measurements to classify or identify neuroendocrine cancer in clinical samples, including formalin-fixed, paraffin-embedded samples.

Career Highlights

Catherine has worked with several reputable organizations throughout her career. Notably, she has been associated with Biotheranostics, Inc. and the General Hospital Corporation. Her work in these institutions has allowed her to advance her research and contribute to innovative solutions in cancer treatment.

Collaborations

Catherine has collaborated with esteemed colleagues, including Yi Zhang and Mark G. Erlander. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Catherine A. Schnabel's innovative work in cancer research exemplifies her dedication to improving patient outcomes. Her patents and collaborations highlight her significant contributions to the medical field. Through her efforts, she continues to pave the way for advancements in cancer treatment and diagnosis.